LIGHD is part of a Sequencing Hub of the COVID Human Genetic Effort, Iternational consortium aiming to discover monogenic inborn errors of immunity, rare or common, underlying severe forms of COVID-19 in previously healthy individuals.

LIGHD is participant in the European project: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine.

You can collaborate as clinician sharing samples from patients or by donations for funding this project. Contact: rebeca.perez@idipaz.es

Project funded by:

– Instituto de Salud Carlos III: Project COV20/01333

– European Commission: UNDINE_Grant agreement ID: 101057100